首页 > 市场调查报告书 > 製药

人工授精市场规模、份额和成长分析（按类型、来源、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1896101

人工授精市场规模、份额和成长分析（按类型、来源、最终用户和地区划分）—产业预测（2026-2033 年）

Artificial Insemination Market Size, Share, and Growth Analysis, By Type (Intrauterine, Intravaginal), By Source Type (AIH-Husband, AID-Donor), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 159 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，人工授精市场规模将达到 23.8 亿美元，到 2025 年将达到 25.7 亿美元，到 2033 年将达到 47.5 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.01%。

人工授精市场正经历显着成长，这主要得益于辅助生殖技术需求的不断增长以及不孕症盛行率的上升。生活方式的改变以及子宫卵巢异位症和多囊性卵巢症候群（PCOS）等疾病的出现，推动了对这些技术的需求。人工授精在发展中地区的普及和应用也促进了市场扩张。先进的精子和卵子选择方法、冷冻保存技术以及胚胎胚胎着床前遗传学检测等创新技术也在推动市场发展。此外，同性婚姻、LGBT族群生育子女以及捐赠生殖细胞的普及也促进了市场动态。政策的完善、对不孕症和人工授精的认识和教育的提高、保险覆盖范围的扩大以及生育年龄的延迟等趋势，都进一步推动了这一新兴领域的需求增长。

全球人工授精市场按类型、来源、最终用途和地区进行细分。按类型划分，可细分为子宫腔内、子宫颈内、阴道内及输卵管内授精。依来源划分，可细分为丈夫供精人工授精（AIH）及捐精人工授精（AID）。依最终用途划分，可细分为生育诊所及其他机构及家庭使用。按地区划分，可细分为北美、亚太、欧洲、拉丁美洲以及中东和非洲。

人工授精市场驱动因素

全球不孕症的上升显着推动了人工授精市场的需求。随着受孕延迟、生活方式改变、环境因素以及生殖健康疾病的日益普遍，人工授精已成为自然受孕困难夫妇和个人的重要解决方案。辅助生殖技术为那些饱受不孕症困扰的人们提供了探索新希望的重要途径。此外，人们对不孕症治疗的认知和接受度不断提高，以及对先进辅助生殖技术的兴趣日益浓厚，进一步推动了人工授精的普及，并支撑着市场成长，以满足这些迫切的需求。

人工授精市场的限制

人工授精市场面临许多挑战，其中治疗程序、药物及相关医疗费用高昂是主要原因。对于许多个人和夫妇而言，尤其是在不孕症治疗保险覆盖率较低的地区，这些服务可能难以负担。这种经济障碍对低收入群体的影响尤其严重，限制了他们获得生殖健康服务的机会。为了解决这个问题并提高服务的可近性，至关重要的是推广降低成本和提高可负担性的策略。采取措施减轻经济负担将使更多人能够受益于人工授精服务。

人工授精市场趋势

人工授精市场正经历创新辅助生殖技术应用的稳定成长趋势，这些技术在提高怀孕率的同时，最大限度地减少了侵入性。先进的基因筛检、冷冻保存和高科技精子处理技术等方法正在革新辅助生殖领域。胚胎胚胎着床前遗传学检测（PGT）便是其中一项进步，它能够在胚胎胚胎着床前检测出遗传疾病，让准父母更加安心。此外，精子冷冻和解冻技术的改进也为患者提供了更多选择和柔软性。这种对技术进步的关注正在推动市场成长，促进更个人化的治疗通讯协定，并显着提高人工授精的成功率。

Genea Pty Limited
Vitrolife
Rinovum Women's Health, LLC
Pride Angel
HI-TECH SOLUTIONS
FUJIFILM Irvine Scientific
Kitazato Corporation
Rocket Medical plc
Conceivex, Inc.
Genea Limited
Genus plc.
Zoetis Inc.
ABS Global
Hamilton Thorne Inc.
Continental Genetics
Select Series
Neogen Corporations
Agtech inc
Imv Technologies
TenderNeeds Fertility LLC

结论与建议

简介目录

Product Code: SQMIG35A2961

Artificial Insemination Market size was valued at USD 2.38 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 4.75 Billion by 2033, growing at a CAGR of 8.01% during the forecast period (2026-2033).

The artificial insemination market is experiencing significant growth driven by a rising demand for assisted reproductive technologies and an increasing prevalence of infertility issues. Lifestyle changes and medical conditions like endometriosis and PCOS have heightened the need for these techniques. The growing acceptance and accessibility of artificial insemination in developing regions further bolster market expansion. Innovations such as advanced sperm and egg selection methods, alongside cryopreservation and pre-implantation genetic testing, are also propelling development. Additionally, the acceptance of same-sex marriage, LGBT parenting, and the availability of donor gametes contribute to market dynamics. Enhanced policies, increasing awareness, educational initiatives on infertility and artificial insemination, insurance coverage, and a trend toward delayed childbearing are further fueling demand in this evolving sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Artificial Insemination Market Segments Analysis

The Global Artificial Insemination Market is segmented into Type, Source Type, End Use, and Region. Based on Type, the market is segmented into Intrauterine, Intracervical, Intravaginal, and Intratubal. Based on Source Type, the market is segmented into AIH-Husband and AID-Donor. Based on End Use, it is segmented into Fertility Clinics & Other Facilities, and Home. Based on Region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Artificial Insemination Market

The rising global infertility rates are significantly driving the demand for the artificial insemination market. As delayed conception, shifting lifestyles, environmental factors, and increasing reproductive health disorders become more prevalent, artificial insemination emerges as a crucial solution for couples and individuals facing challenges in achieving natural conception. Assisted reproductive technology serves as a vital option, enabling those struggling with infertility to explore new possibilities. Additionally, growing awareness and acceptance of fertility treatments, coupled with heightened interest in advanced reproductive methods, further enhance the adoption of artificial insemination, fostering market growth in response to these pressing needs.

Restraints in the Artificial Insemination Market

The artificial insemination market faces significant challenges due to the high costs associated with treatment procedures, medications, and related medical expenses, which can make these services unaffordable for many individuals and couples, particularly in areas where insurance coverage for infertility treatments is inadequate. This financial barrier disproportionately affects lower-income populations, limiting their access to reproductive health options. To address this issue and improve accessibility, it is crucial to pursue strategies aimed at reducing costs and enhancing affordability. By implementing measures that alleviate the financial burden, a broader demographic can benefit from artificial insemination services.

Market Trends of the Artificial Insemination Market

The Artificial Insemination market is witnessing a robust trend towards the increased utilization of innovative reproductive technologies that enhance conception rates while minimizing invasiveness. Techniques such as advanced genetic screening, cryopreservation, and high-tech sperm processing are revolutionizing the landscape of assisted reproduction. Preimplantation genetic testing exemplifies these advancements by enabling the detection of genetic disorders in embryos prior to implantation, offering parents greater reassurance. Furthermore, improvements in sperm freezing and thawing processes provide patients with enhanced options and flexibility. This focus on technological advancement is driving market growth, fostering more personalized treatment protocols, and significantly improving success rates in artificial insemination procedures.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
PESTEL Analysis
Macro-Economic Indicators
Trade Analysis

Global Artificial Insemination Market Size by Type & CAGR (2026-2033)

Intrauterine Insemination
Intracervical Insemination
Intravaginal Insemination
Intratubal Insemination

Global Artificial Insemination Market Size by Source Type & CAGR (2026-2033)

AIH-Husband
AID-Donor

Global Artificial Insemination Market Size by End User & CAGR (2026-2033)

Fertility clinics & other facilities
Home

Global Artificial Insemination Market Size by Region & CAGR (2026-2033)

North America, (Type, Source, End User)
- US
- Canada
Europe, (Type, Source, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Type, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Type, Source, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Type, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Genea Pty Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rinovum Women's Health, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pride Angel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HI-TECH SOLUTIONS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Irvine Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kitazato Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rocket Medical plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conceivex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genus plc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABS Global
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Thorne Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Continental Genetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Select Series
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporations
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agtech inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imv Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TenderNeeds Fertility LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Conclusion & Recommendation

02-2729-4219

+886-2-2729-4219

License/价格

人工授精市场规模、份额和成长分析（按类型、来源、最终用户和地区划分）—产业预测（2026-2033 年）

Artificial Insemination Market Size, Share, and Growth Analysis, By Type (Intrauterine, Intravaginal), By Source Type (AIH-Husband, AID-Donor), By End User, By Region - Industry Forecast 2026-2033

目录

介绍

调查方法

执行摘要

市场动态与展望

关键市场考察

全球人工授精市场规模（按类型及复合年增长率划分）（2026-2033 年）

全球人工授精市场规模（依来源类型及复合年增长率划分）（2026-2033 年）

全球人工授精市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

全球人工授精市场规模（按地区划分）及复合年增长率（2026-2033 年）

竞争资讯

主要企业简介